Page 24 - AN-1-1
P. 24
Advanced Neurology AIS in patients with COVID-19
https://doi.org/10.1016/j.bbih.2020.100137 stroke in six patients following SARS-CoV-2 infection:
A retrospective case study series of acute thrombotic
51. Khandelwal P, Al-Mufti F, Tiwari A, et al., 2021, Incidence,
characteristics and outcomes of large vessel stroke in complications on stable underlying atherosclerotic disease.
COVID-19 cohort: An international multicenter study. Eur J Neurol, 27(11): 2308–2311.
Neurosurgery, 89(1): E35-E41. https://doi.org/10.1111/ene.14466
https://doi.org/10.1093/neuros/nyab111 60. Wang A, Mandigo GK, Yim PD, et al., 2020, Stroke and
52. Avula A, Nalleballe K, Narula N, et al., 2020, COVID-19 mechanical thrombectomy in patients with COVID-
presenting as stroke. Brain Behav Immun, 87: 115–119. 19: technical observations and patient characteristics.
J Neurointerv Surg, 12(7): 648–653.
https://doi.org/10.1016/j.bbi.2020.04.077
https://doi.org/10.1136/neurintsurg-2020-016220
53. Di Napoli M, Papa F, Bocola V, 2001, Prognostic influence
of increased C-reactive protein and fibrinogen levels in 61. Li G, Han C, Xia X, et al., 2021, Relationship of uric acid,
ischemic stroke. Stroke, 32(1): 133–138. C-reactive protein, and N-terminal pro-B-type natriuretic
peptide with acute cerebral infarction. Rev Assoc Med Bras,
https://doi.org/10.1161/01.str.32.1.133 (1992), 67(11): 1639–1643.
54. Mobarra N, Morovatdar N, Di Napoli M, et al., 2019, The https://doi.org/10.1590/1806-9282.20210693
association between inflammatory markers in the acute
phase of stroke and long-term stroke outcomes: Evidence 62. Zi WJ, Shuai J, 2014, Plasma D-dimer levels are associated
from a population-based study of stroke. Neuroepidemiology, with stroke subtypes and infarction volume in patients with
53(1-2): 20–26. acute ischemic stroke. PLoS One, 9(1): e86465.
https://doi.org/10.1159/000494685 https://doi.org/10.1371/journal.pone.0086465
55. Luan YY, Yin CH, Yao YM, 2021, Update advances on 63. Bikdeli B, Madhavan MV, Jimenez D, et al., 2020, COVID-
C-reactive protein in COVID-19 and other viral infections. 19 and thrombotic or thromboembolic disease: Implications
Front Immunol, 12: 720363. for prevention, antithrombotic therapy, and follow-up:
JACC State-of-the-art review. J Am Coll Cardiol, 75(23):
https://doi.org/10.3389/fimmu.2021.720363 2950–2973.
56. Snell J, 2021, SARS-CoV-2 infection and its association with https://doi.org/10.1016/j.jacc.2020.04.031
thrombosis and ischemic stroke: A review. Am J Emerg Med,
40: 188–192. 64. Mijajlovic MD, Pavlović A, Brainin M, et al., 2017, Post-
stroke dementia a comprehensive review. BMC Med,
https://doi.org/10.1016/j.ajem.2020.09.072 15(1): 11.
57. Patone M, Mei XW, Handunnetthi L, et al., 2022, Risks of 65. Parsay S, Vosoughi A, Khabbaz A, et al., 2021, The incidence
myocarditis, pericarditis, and cardiac arrhythmias associated and mortality ratio of ischemic cerebrovascular accidents in
with COVID-19 vaccination or SARS-CoV-2 infection. Nat COVID-19 cases: A systematic review and meta-analysis.
Med, 28(2): 410–422. J Stroke Cerebrovasc Dis, 30(3): 105552.
https://doi.org/10.1038/s41591-021-01630-0
https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105552
58. Zhang L, Yan X, Fan Q, et al., 2020, D-dimer levels on 66. Strambo D, De Marchis GM, Bonati LH, et al., 2021, Ischemic
admission to predict in-hospital mortality in patients with stroke in COVID-19 patients: Mechanisms, treatment and
Covid-19. J Thromb Haemost, 18(6): 1324–1329.
outcomes in a consecutive Swiss Stroke Registry analysis.
https://doi.org/10.1111/jth.14859 Eur J Neurol, 29(3): 732–743.
59. Lapergue B, Lyoubi A, Meseguer E, et al., 2020, Large vessel https://doi.org/10.1111/ene.15199
Volume 1 Issue 1 (2022) 16 https://doi.org/10.36922/an.v1i1.28

